Overview
Dr. Arnold focuses on outcome research to demonstrate the cost-effectiveness of the therapies she uses. This includes incorporating patient reported outcomes, like quality of life, to survival and cost analysis. She hopes to demonstrate that novel therapies are effective and valuable because they enable children to grow up to become healthy, productive citizens in our society.
Her research incorporates local and national collaborations, which include the: Emory Pediatrics Qualitative Research Core, North American Pediatric Aplastic Anemia Consortium, and Sickle Cell Transplant Advocacy and Research Alliance.
Cameron Baldes, MD, Pediatrics Resident, Emory University, 2019-2020
Current Project: Pediatric Intensive Care Resource Utilization Following Hematopoietic Cell Transplantation in Children with Acute Leukemia
Thomas Michniacki, MD, Clinical lecturer, C.S. Mott Children's Hospital, 2018-Present
Current Project: Treatment-related Patient Reported Outcomes in Severe Pediatric Aplastic Anemia
Jasmine Smith, MD (ASH Minority Medical Student Award Program Participant)
Project: Hematopoietic Cell Transplant for Sickle Cell Disease: Understanding Awareness of this Curative Therapy
Brousseau DC, Richardson T, Hall M, Ellison AM, Shah SS, Raphael JL, Bundy DG, Arnold S. Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children. Pediatrics. 2019 Jul;144(1). doi: 10.1542/peds.2018-3285. PubMed PMID: 31227564.
Burns LJ, Abbetti B, Arnold SD, Bender J, Doughtie S, El-Jawahiri A, Gee G, Hahn T, Horowitz MM, Johnson S, Juckett M, Krishnamurit L, Kullberg S, LeMaistre CF, Loren A, Majhail NS, Murphy EA, Rizzo D, Roche-Green A, Saber W, Schatz BA, Schmit-Pokorny K, Shaw BE, Syrjala KL, Tierney DK, Ullrich C, Vanness DJ, Wood WA, Denzen EM. Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2018 Jun;24(6):1111-1118. doi: 10.1016/j.bbmt.2018.01.029. Epub 2018 Feb 3. PubMed PMID: 29408289; PubMed Central PMCID: PMC5993588.
Szymczak JE, Getz KD, Madding R, Fisher B, Raetz E, Hijiya N, Gramatges MM, Henry M, Mian A, Arnold SD, Aftandilian C, Collier AB, Aplenc R. Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemia. Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26927. Epub 2017 Dec 29. PubMed PMID: 29286570; PubMed Central PMCID: PMC6857179.
Bundy DG, Richardson TE, Hall M, Raphael JL, Brousseau DC, Arnold SD, Kalpatthi RV, Ellison AM, Oyeku SO, Shah SS. Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest Syndrome. JAMA Pediatr. 2017 Nov 1;171(11):1090-1099. doi: 10.1001/jamapediatrics.2017.2526. PubMed PMID: 28892533; PubMed Central PMCID: PMC5710371.
Arnold SD, Brazauskas R, He N, Li Y, Aplenc R, Jin Z, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Majhail NS, Diaz MA, Freytes CO, Wood WA, Savani BN, Kamble RT, Parsons S, Ahmed I, Sullivan K, Beattie S, Dandoy C, Munker R, Marino S, Bitan M, Abdel-Azim H, Aljurf M, Olsson RF, Joshi S, Buchbinder D, Eckrich MJ, Hashmi S, Lazarus H, Marks DI, Steinberg A, Saad A, Gergis U, Krishnamurti L, Abraham A, Rangarajan HG, Walters M, Lipscomb J, Saber W, Satwani P. Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. Haematologica. 2017 Nov;102(11):1823-1832. doi: 10.3324/haematol.2017.169581. Epub 2017 Aug 17. PubMed PMID: 28818869; PubMed Central PMCID: PMC5664386.
NIH-NHLBI - 1 K23 HL143164-01 – 2018-2022
Career Development Award
Role: PI
NHLBI – 2019-2020
Cure Sickle Cell Initiative Award
Role: Co-I
PI: Krishnamurti